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Abstract: 
Depriving cells of iron likely stresses them and can result in cell death. To examine the potential relationship 
between this form of stress and cell death, Jurkat T-lymphocytes were made iron-deficient by exposing them to 
the iron chelator, deferoxamine (DFO). Such treatment produced evidence of apoptosis, including cell 
shrinkage, membrane blebbing, chromatin condensation and fragmentation, and also formation of apoptotic 
bodies. Additionally, proteolytic cleavage of poly(ADP-ribose)polymerase was detected, suggesting 
involvement of caspases in initiating apoptosis. Indeed, a selective caspase-3 inhibitor prevented the effects of 
DFO. During the early induction period of apoptosis, GRP78 and HSP70 mRNA expression was not affected. 
In contrast, there was mainly increased mRNA expression of Growth Arrest and DNA Damage-inducible gene 
153 (GADD153), which seemed to be at the level of transcription rather than mRNA stability. Furthermore, 
fortifying cells with antioxidants did not prevent the increased GADD 153 mRNA expression, and no evidence 
of single-strand breaks in DNA was found, suggesting that neither reactive oxygen species nor DNA damage 
was involved in triggering GADD153 gene activation. DFO also caused GADD153 protein to be expressed. 
Because GADD153 is recognized as a pro-apoptotic gene, these findings generate the notion that GADD153 
might help mediate apoptosis in iron-deficient cells. 
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Article: 
1. Introduction 
Proper levels of iron are needed by cells to help ensure their viability and proliferative capacity. Iron was 
initially recognized as an essential trace element for all dividing cells upon finding that DNA synthesis was 
impaired in human lymphocytes rendered iron-deficient with the iron chelator, deferoxamine (DFO) [1]. This 
effect of cellular iron deficiency can be attributed to decreased activity of ribonucleotide reductase [2], an iron-
dependent enzyme that converts ribonucleotides into deoxyribonucleotides as a prerequisite step for DNA 
synthesis. As a result, there is growth arrest of iron-deficient cells in the S-phase of the cell cycle [3]. 
Transcriptional activation of certain genes initiates downstream events leading to the cell cycle arrest. For 
example, it is known that DFO-induced cellular iron deficiency increases the levels of transcription factor p53, 
which in turn is directly responsible for activating the CIP-1/WAF-1/SDI1/p21 gene [4]. Subsequently, the p21 
gene product inhibits cyclin-dependent kinases that otherwise would promote cell cycle progression. 
 
When impairment of DNA synthesis and cell division becomes critical, iron-deficient cells start to die with evi-
dence of apoptosis being apparent [5,6], but the precise cell death pathway leading to apoptosis has not been 
completely elucidated. However, there is the suggestion from widely accepted models of apoptosis [7] that iron 
deficiency-induced apoptosis is initiated by caspases. Activation of caspases is pivotal for later occurrence of 
the DNA fragmentation and morphological changes characteristic of apoptosis [8]. Hence, because DNA 
fragmentation [5,6] and morphological changes [6] occur in iron-deficient cells, the possible involvement of 
caspases, specifically caspase-3, in initiating apoptosis in iron-deficient Jurkat T-lymphocytes was initially 
investigated to help clarify the chain of events leading to cell death. 
It is generally believed that changes in gene expression are important in promoting cell death by apoptosis in 
iron-deficient cells. In support of this concept, it has been shown that DFO-induced iron deficiency in human 
breast cancer cells caused apoptosis, which was accompanied by changes in the expression of the pro-apoptotic 
Bax gene and the anti-apoptotic Bcl-2 gene [9]. However, it is conceivable that other genes could also be 
involved in mediating apoptosis in iron-deficient cells. Because depriving cells of iron likely creates a stressful 
cellular environment, another aim of this present study was to determine if the expression of certain stress-
response genes is increased in iron-deficient Jurkat T-lymphocytes, in establishing a possible association 
between the stress-response gene expression and occurrence of cell death. 
 
2. Materials and methods  
2.1. Materials 
Jurkat T-lymphocytes, a human lymphoblastoid T-cell line, were purchased from ATCC (Rockville, MD). 
Deferoxamine mesylate (DFO), 2,2-dipyridyl (DPD), and diethylenetriaminepentaacetic acid (DTPA) and all 
other common reagents were purchased from Sigma Chemical Co. (St. Louis, MO).  
 
2.2. Cell culture and treatment of cells 
Jurkat T-lymphocytes were propagated in RPMI-1640 media (Sigma) supplemented with 100 ml/l fetal bovine 
serum (BioWhittaker Inc., Walkersville, MD), 2 mmol/ l glutamine, 0.54 µmol/l fungizone, 100,000 units/l 
penicillin, and 100 mg/l streptomycin (last four items from Atlanta Biologicals, Atlanta, GA). To make the cells 
iron-deficient [10], they were incubated with 100 µM DFO for periods up to 24 h to chelate intracellular iron. 
DPD and DTPA were utilized similarly to confirm the effects of DFO. Other cell samples were pretreated for 3 
h with 600 µM Ac-DEVDCHO (Calbiochem, San Diego, CA) before exposing them to DFO. In some 
experiments, control cells and cells exposed to DFO were subsequently incubated with actinomycin D (1–5 
µg/ml). In other experiments, cells were pretreated with either α-tocopherol (100 µM) for 24 h, or N-
acetylcysteine (20 mM) for 2 h, before exposing the cells to DFO. 
 
 
2.3. Examination of cells for morphological evidence of apoptosis 
Using an Olympus IX-70 inverted microscope/SPOT digital camera system, 200 randomly selected cells were 
scored visually for the presence of cell shrinkage, plasma membrane blebbing, and/or breakup of the cells into 
apoptotic bodies, which all are basic markers of apoptosis [11]. Additionally, cells were fixed with 4% 
formaldehyde and stained with 1 µg/ml 4' ,6-diamidino-2-phenylindole (DAPI) to visualize the extent of 
chromatin condensation and fragmentation using an Olympus BX-60 fluorescence microscope equipped with a 
UV filter. 
2.4. Detection of proteolytic cleavage of poly-(ADP-ribose)- polymerase (PARP) 
At different time points, cells were harvested and washed with ice-cold phosphate-buffered saline (PBS) and 
then resuspended in PBS containing phenylmethylsulfonyl fluoride (0.1 mg/ml) for sonication on ice. Protein 
concentration of the lysates was determined with a Bio-Rad DC protein assay kit (Bio-Rad, Hercules, CA). 
Next, 30 µg of cellular protein was processed for SDS/PAGE using 12% Trisglycine pre-cast gels (Novex, San 
Diego, CA). The separated proteins on the gels were blotted to nitrocellulose membrane, which was probed 
with a murine anti-PARP antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and then with a 
horseradish peroxidase-conjugated rabbit anti-mouse antibody. Detection of immunosignal was achieved by 
enhanced chemiluminescence (ECL, Amer-sham, Arlington, IL) using Fuji X-ray film. 
 
2.5. Determination of GRP78, HSP70, and Growth Arrest and DNA Damage-inducible gene 153 (GADD153) 
mRNA expression 
Total RNA was isolated from the cells using a Qiagen RNeasy Mini kit. The expression levels of GRP78, 
HSP70, and GADD153 mRNA were determined by multiplex relative RT-PCR analysis of total RNA using a 
Qiagen OneStep RT-PCR kit and gene-specific primers. The PCR primer base sequences for GRP78 and 
HSP70 were from the NCBI UniSTS data-base of NIH. For GRP78 (UniSTS:48897)— forward primer: 
GCCTAAGCGGCTGTTTACTG, reverse primer: AACTTCCTACACCAGATGCACA, PCR product size: 
174–175 (bp). For HSP70 (UniSTS:70149)—forward primer: TGACTGTCAGGGCTATGCTAT, reverse 
primer: CAATGTTAAAGTGCCACACAAG, PCR product size: 203 (bp). The GADD153 PCR primer 
sequences (sense: 5' -GCACCTCCCAGAGCCCTCACTCTCC-3' and anti-sense: 5' -
GTCTACTCCAAGCCTTCCCCCTGCG-3' ) were exactly the same as that used originally by Mertani et al. 
[12] and gave a PCR product size of 422 bp. Either the β-actin or 18S rRNA QuantumRNA primer/competimer 
sets (Ambion, Inc., Austin, TX) were used to generate internal standards with cDNA product sizes of 294 and 
495 bp, respectively. The RT-PCR conditions for GRP78 and HSP70 were 30 min at 48 °C followed by 15 min 
at 95 °C (RT), then 0.5 min at 94 °C, 0.5 min at 48 °C, and 1 min at 72 °C for 32 cycles (GRP-78) or 34 cycles 
(HSP-70) (PCR). The RT-PCR conditions for GADD153 were 30 min at 50 °C followed by 15 min at 95 °C 
(RT), then 0.5 min at 95 °C, 0.5 min at 60 °C, and 1 min at 72 °C for 25 cycles (PCR). The resulting cDNA 
products were separated by 2% agarose gel electrophoresis with ethidium bromide staining. 
 
2.6. Determination of GADD153 protein expression 
Cells were harvested and washed by centrifugation (500 × g for 5 min) in Hanks Balanced Salt Solution 
(HBSS). The cell pellets were frozen at — 80C. To prepare whole cell lysates, the frozen cell pellets were 
thoroughly resuspended in lysis buffer (50 mM Tris–HCl, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium 
deoxycholate, 1 mM sodium orthovanadate, 1 mM sodium fluoride, Complete Protease Inhibitor Cocktail from 
Roche-Boehringer Mannheim, pH 7.4) and left on ice for 30 min. Next, the samples were centrifuged at 16,000 
× g for 20 min at 4C. The protein concentrations of the whole cell lysates (supernatant) were determined with a 
BCA protein assay kit (Pierce Inc.). 
 
For electrophoresis, whole cell lysates (50-µg protein) were loaded into the wells of Novex pre-cast NuPAGE 
mini-gels (4–12% Bis-Tris). The gel-separated proteins were transferred to nitrocellulose membrane (Pierce), 
which was then incubated for 1 h at 25 C in blocking buffer consisting of 5% skim milk powder in TBST (20 
mM Tris– HCl, 150 mM sodium chloride, 0.05% Tween 20, pH 7.4). Next, the nitrocellulose membrane was 
incubated overnight at 4C with GADD153 rabbit polyclonal R-20 antibody (Santa Cruz) in blocking buffer 
(1:5000). After washing in TBST, the membrane was then incubated 2 h at 25C with goat anti-rabbit IgG/HRP 
conjugate (Santa Cruz) in blocking buffer (1:100,000). Finally, after washing again in TBST, the membrane 
was placed in a plastic pouch for incubation with chemiluminescent reagent (Pierce Super-Signal WestFemto 
Maximum Sensitivity Substrate) for 5 min for subsequent analysis on a Kodak digital science'' image station 
440 CF. After densitometry, the nitrocellulose membrane was kept in the plastic pouch and in the dark at 25 °C 
overnight, before reprobing for β-actin as a control for sample loading onto the gels. The membrane was 
washed with TBST, and incubated 2 h at 25 °C with mouse monoclonal anti-β-actin antibody (Sigma) in 
blocking buffer (1:50,000). After incubation for 1 h at 25 °C with HRPconjugated goat polyclonal anti-mouse 
IgG (Santa Cruz) in blocking buffer (1:100,000), the membrane was washed in TBST and processed for 
analysis as before. 
         
 
2.7. Assessment of DNA damage 
Single-strand breaks in DNA were assessed in the cells by the comet assay, as previously described [13]. 
Basically, cells resuspended in agarose gel were cast onto glass slides. Following treatment of the supported 
cells with alkaline detergent to remove membranes, the resulting nucleoids were subjected to electrophoresis. 
Nucleoid DNA was stained with ethidium bromide to permit visualization by fluorescence microscopy. 
 
2.8. Statistical analysis of data 
Where applicable, data were analyzed for statistical differences by analysis of variance (ANOVA) using a stan-
dard SAS program (version 6.12). 
 
3. Results 
3. 1. Morphological changes in iron-deficient cells 
Upon examination by phase-contrast light microscopy (Fig. 1A), control or iron-sufficient cells were whole 
with smooth surface membranes. From this single view alone, none of the cells had irregular morphology. 
Nevertheless, after total scoring, about 5% of control cells were judged to have a morphological appearance 
characteristic of apoptosis, which is a percentage typically expected in culturing Jurkat T-lymphocytes. In 
contrast, many of the DFO-treated cells looked irregular. That is, after total scoring, about 40% of the cells were 
shrunken, had blebbing surface membranes, and/ or were in the process of breaking up into small apoptotic 
bodies. After DAPI-staining of the cells for examination by fluorescence microscopy (Fig. 1B), it can be seen 
that chromatin was mainly intact in nuclei of control cells, in marked contrast to the chromatin in many of the 
DFO-treated cells. More specifically, after total scoring, 2% of control cells and 48% of DFO-treated cells had 
chromatin condensation and/or fragmentation. Thus, these particular findings provide further morphological 
evidence of apoptosis in iron-deficient Jurkat T-lymphocytes. 
 
3.2. Degradation of PARP in iron-deficient cells 
In popular models of apoptosis [7], caspases are activated to function in the enzymatic degradation of numerous 
intracellular proteins having vital metabolic roles. PARP, which is involved in DNA repair, is a primary 
example of a protein degraded or cleaved by activated caspases during apoptosis [14]. Accordingly, to 
determine if PARP cleavage occurred in DFO-treated Jurkat T-lymphocytes, Western-blotting analysis was 
performed (Fig. 2A). PARP was detected as a band with an apparent molecular mass of 113 kDa. Following 
exposure of cells to DFO, a PARP cleavage product having an apparent molecular mass of 89 kDa was also 
detected. This product was not detectable until 10 h after exposing the cells to DFO, with peak appearance 
between 14 and 18 h. Therefore, the occurrence of PARP cleavage in the iron-deficient Jurkat T-lymphocytes 
strongly suggested that caspases could have been activated because caspases are known to be responsible for 
PARP cleavage [15,16]. 
 
3.3. Requirement for caspase-3 in mediating cell death induced by DFO 
Morphological features of apoptosis are known to become apparent as a result of caspase-3 action [8]. Further-
more, caspase-3 is known to recognize PARP as a substrate and catalyze its cleavage [14]. Hence, to determine 
the requirement for caspase-3 in mediating cell death in iron-deficient Jurkat T-lymphocytes, we utilized the 
selective caspase-3 inhibitor, Ac-DEVD-CHO [17]. As shown in Fig. 2B, less than 5% of the control cells (i.e., 
cells not treated with DFO and/or Ac-DEVD-CHO) showed morphological evidence of apoptosis. However, 
more than 35% of the cells exposed to DFO had apoptotic morphology, but pretreating cells with Ac-DEVD-
CHO prevented this effect by DFO. The eventual longer-term fate of these caspase-3 inhibitor-treated, iron-
deficient cells was not determined. However, it is likely that they would not survive without a source of iron. 
Thus, it is conceivable that either necrosis occurs or a caspase-3-independent cell death pathway is initiated in 
such cells. 
 
3.4. Effect of cellular iron deficiency on GRP78, HSP70, and GADD153 mRNA expression 
GRP78 and HSP70 are two stress genes that are frequently activated in cells as an early response to being 
exposed to a stressful environment. Because making cells iron-deficient likely stresses them, GRP78 and 
HSP70 mRNA expression was determined in iron-deficient Jurkat T-lymphocytes (Fig. 3A). As can be seen, 
cellular iron deficiency induced by DFO did not change mRNA expression of either GRP78 (top gel) or HSP70 
(bottom gel) when evaluated for periods up to 18 h after initially treating the cells with DFO. In contrast, there 
was increased expression of GADD153 mRNA, which was detectable by 10 h (data not shown) but with peak 
expression occurring at 15–16 h as shown by the representative results from two different experiments (Fig. 
3B). 
 
To provide further support that the effect of DFO on GADD153 mRNA expression was due to iron deprivation, 
two other compounds generally recognized as iron chelators were tested. Either 2,2-dipyridyl (DPD) or 
diethylenetriaminepentaacetic acid (DTPA) increased GADD153 mRNA expression as well in Jurkat T-
lymphocytes (Fig. 4A). To determine whether the changes in GADD153 mRNA levels reflected changes in 
GADD153 protein levels, Western immunoblotting analysis was performed. As can be seen (Fig. 4B), DFO, 
DPD, and DTPA each induced GADD153 protein expression. In the case of DFO, it was further found that co-
treating Jurkat T-lymphocytes with 100 µM DFO and 50 µM ferrous sulfate prevented up-regulation of 
GADD153 mRNA and protein expression (Fig. 4A and B), suggesting that the effect of DFO on GADD153 
mRNA expression was due to chelation of iron and not other metal ions.  
               
 
 
 
3.5. Evidence that the increased GADD153 mRNA expression caused by DFO is at the level of transcription 
To come up with a fundamental explanation for the increased GADD153 mRNA expression in iron-deficient 
Jurkat T-lymphocytes, a standard experiment utilizing actinomycin D (ACT) was performed to inhibit or block 
transcription (Fig. 5A). Cells in complete culture media were incubated first with DFO for 8 h. Then, ACT was 
added, and the incubation continued for 4 h. As can be seen by the data, exposing cells to only DFO increased 
GADD153 mRNA expression (lane 3) when compared to control cells (lane 2). This effect by DFO was 
prevented when cells were treated with ACT after being exposed to DFO (lane 4). In other experiments, 
GADD153 mRNA stability was not different between control cells and cells exposed to DFO, as can be seen in 
comparing GADD153 mRNA expression levels over the course of 6 h after blocking transcription with ACT 
following the exposure of cells to DFO for 14 h (Fig. 5B). Moreover, after densitometric analysis of the Fig. 5B 
data and subsequent plotting, no notable difference in the rate of GADD153 mRNA decay can be seen when 
comparing the relative slopes of the plots for control versus DFO-treated cells (Fig. 5C). 
 
 
3.6. Evaluation of oxidative stress in contributing to up-regulation of GADD153 mRNA expression 
Because GADD153 is often activated as a result of oxidative stress and DNA damage, the effect of antioxidants 
on GADD153 mRNA levels was determined. Pretreatment of Jurkat T-lymphocytes with either α-tocopherol 
(Fig. 6A) or N-acetylcysteine (Fig. 6B) failed to prevent DFO-induced up-regulation of GADD153 mRNA 
expression, suggesting that reactive oxygen species were not involved in GADD153 mRNA up-regulation. 
Furthermore, as assessed by the comet assay, single-strand breaks in DNA were not detected in DFO-treated 
Jurkat T-lymphocytes (Fig. 7), suggesting that oxidative DNA damage was not promoted by cellular iron 
deficiency, and hence, could not have led to up-regulation of GADD153 mRNA expression. As the rest of the 
data show, DFO actually inhibited H2O2-induced DNA damage to a large extent, likely because DFO chelated 
intracellular iron, which otherwise can react with H2O2 to form hydroxyl radical that ultimately damages 
cellular DNA. 
 
4. Discussion 
In the current study, DFO was the primary iron chelator utilized to make Jurkat T-lymphocytes iron-deficient. 
Cellular uptake of DFO occurs by endocytosis [18]. Subsequently, the DFO compartmentalizes largely in 
lysosomes, which contain a sizable pool of redox-active iron originating apparently from lysosomal proteolysis 
of iron-containing proteins [19]. Hence, this free iron in lysosomes, which may help meet the overall needs of 
the cell, is chelated by DFO. The unavailability or deficiency of iron induced by DFO can result in cell death. 
For example, HL-60 cells died when these cells were made iron-deficient by exposing them to DFO [5]. Such 
cell death was suggested to have occurred by way of apoptosis, based on the observation of a few cellular 
features characteristic of apoptosis. In support of this previous study [5], the present study found that DFO, or 
the iron deficiency caused by DFO, caused morphological features characteristic of apoptosis to appear in 
Jurkat T-lymphocytes. At least 10–12 h of exposure of the cells to DFO was required before any cell shrinkage, 
membrane blebbing, apoptotic bodies, and chromatin condensation and fragmentation were detectable. To 
expand these basic observations, the present results suggest that DFO-induced iron deficiency caused cell death 
in Jurkat T-lymphocytes via a caspase-3 -dependent pathway leading to apoptosis. Two lines of evidence 
support this view. First, cleavage of PARP was detected in DFO-treated cells. It is well established that PARP 
can be cleaved by caspase-3 [14]. Second, the morphological changes caused by DFO were not seen in Jurkat 
T-lymphocytes that were pretreated with the caspase3 inhibitor, Ac-DEVD-CHO, prior to their subsequent 
exposure to DFO. This finding is consistent with the results of other investigators [8] who reported that caspase-
3 activity is required for the morphological changes associated with apoptosis. 
 
The upstream events leading to activation of caspase-3 in DFO-treated Jurkat T-lymphocytes remain unknown. 
However, based on two popular models for apoptosis [7], the DFO-induced cell death could have been initiated 
via either of two apoptotic pathways. Basically, in the cell surface death receptor pathway, trimerization of cell 
surface receptors, such as FAS (CD95), leads to activation of initiator caspases, such as caspase-8. In turn, 
caspase-8 activates the effector caspase known as caspase-3, which is the main executioner of cells [20]. 
Activated caspase-3 ultimately commits the cell to death by cleaving p21 [21], thereby removing the p21 that 
promotes cell cycle arrest. On the other hand, in the mitochondria-mediated cell death pathway, disruption of 
mitochondrial membrane potential and structural integrity occurs initially. These events permit release of 
cytochrome c, which, along with Apaf-1 and (d)ATP, forms the apoptosome. This complex activates caspase-9, 
which in turn activates caspase-3. Thus, no matter which cell death pathway is followed by iron-deficient Jurkat 
T-lymphocytes, caspase-3 would be pivotal for the process of apoptosis since the cell surface death receptor 
pathway and mitochondria-mediated cell death pathway converge to result in the activation of caspase-3. 
 
By exposing Jurkat T-lymphocytes to DFO, it is likely that this treatment created a stressful cellular 
environment because the cells were deprived of a critical micronutrient needed for their vitality and viability. 
As such, it would be expected that stress-response genes become activated in helping the iron-deficient cells to 
either survive or terminate. Although GRP78 and HSP70 mRNA expression was not affected by the cellular 
iron deficiency induced by DFO, an important member of the GADD was up-regulated. More specifically, 
GADD153 mRNA expression was increased, which could be potentially due to increased transcription or 
greater mRNA stability. Depriving cells of leucine [22] increased GADD153 mRNA expression, which was 
attributed to increased transcription and mRNA stability. Glutamine deprivation also induced GADD153 
mRNA expression [23], but the primary mechanism was through mRNA stabilization. The increased GADD153 
mRNA in iron-deficient Jurkat T-lymphocytes seemed to be at the level of transcription based on two 
observations. First, actinomycin D prevented the increased GADD153 mRNA expression caused by DFO. 
Second, GADD153 mRNA stability was not different in untreated versus DFO-treated Jurkat T-lymphocytes. 
 
GADD genes are typically activated when cells are subjected to various forms of stress. For example, GADD 
mRNA expression increased in cells upon exposure to stress-inducing agents, such as peroxynitrite [24], UV 
radiation [25], and anti-cancer drugs [26], which also are known to induce DNA damage. Most interesting and 
relevant to the current effects of cellular iron deficiency on GADD153 mRNA expression, depriving cells of 
individual nutrients such as leucine [22], glutamine [23], glucose [27], and zinc [28] created a cellular 
environment that led to increased GADD153 gene expression. The molecular cascade leading to GADD153 
gene activation is known to involve mitogen-activated protein kinases (MAPK). When p38/SAPK2 was 
activated by anisomycin in Jurkat T-lymphocytes, the levels of GADD153 transcript increased, but this effect 
was nullified with a selective chemical inhibitor of p38/SAPK2 [29]. 
 
Although cellular DNA damage can result in up-regulation of GADD153 gene expression, it is important to 
note that up-regulation of GADD gene expression does not necessarily occur merely as a consequence of 
growth arrest or DNA damage. Indeed, regarding the latter situation, single-strand breaks in DNA as assessed 
by the comet assay were not detected in DFO-treated Jurkat T-lymphocytes. This finding suggests that DFO did 
not induce oxidative stress, at least to a sufficient extent to cause single-strand breaks in DNA. Instead, it was 
found that DFO had the capability to inhibit H2O2-induced DNA damage in Jurkat T-lymphocytes. In inducing 
DNA damage, it is generally believed that H2O2 diffuses through cellular membranes, including the nuclear 
membrane. The incoming H2O2 reacts with transition metals such as ferrous ions that are in close proximity or 
loosely bound to DNA, resulting in the formation of hydroxyl radicals that cause oxidative damage to DNA. 
However, a series of recent studies [19,30,31] have advanced the concept that H2O2 enters lysosomes and reacts 
with redox-active iron originating from lysosomal degradation of metalloproteins. The hydroxyl radicals formed 
then cause rupture of the lysosomes. This allows some of the redox-active iron to reach the nucleus and react 
with H2O2 to form hydroxyl radicals that damage DNA. Consequently, cell cycle arrest and/or apoptosis occur. 
All of these events induced by H2O2 can be prevented by DFO, which has been attributed to the capacity of 
DFO to chelate redox-active iron in the lysosomal but also endosomal compartments of the cell [19,30,31]. 
 
The function of the GADD153 gene product is not completely known. However, GADD153 protein belongs to 
the CCAAT/enhancer binding protein (C/EBP) family of transcription factors [32]. There is evidence that 
GADD153 is directly involved in triggering apoptosis, based primarily on the finding that targeted 
overexpression of a GADD153 vector in several different cell lines resulted in apoptosis [33]. Furthermore, 
several recent studies [26,34–36] have suggested that the increased GADD153 gene expression caused by 
various inducers of apoptosis somehow triggers the critical early events leading to the initiation of apoptosis. 
Therefore, because there is substantial evidence to support the concept that GADD153 has a role in triggering 
apoptosis, it is conceivable that the increased GADD153 protein expression in iron-deficient Jurkat T-
lymphocytes could be involved in triggering apoptosis in these cells. This is not to say, however, that other 
apoptosis-related genes or gene products are unimportant in the apoptosis induced by DFO. In particular, one 
study has suggested a potential role for the Bcl-2 gene family, based on the finding that DFO induced apoptosis 
in MCF-7 human breast cancer cells, in association with changes in the expression of the pro-apoptotic Bax 
gene and the anti-apoptotic Bcl-2 gene [9]. Thus, besides GADD153 gene expression being changed, it is 
possible that Bax and Bcl-2 gene expression was changed as well in DFO-treated Jurkat T-lymphocytes in 
helping to trigger apoptosis. 
 
In conclusion, DFO-induced iron deficiency in Jurkat T-lymphocytes caused caspase-3-dependent programmed 
cell death, in association with increased GADD153 mRNA expression that was due to increased transcription 
rather than increased stability. The effect of cellular iron deficiency on GADD153 mRNA did not seem to 
involve reactive oxygen species, and, accordingly, was not a consequence of oxidative DNA damage. Because 
GADD153 protein was expressed as a result of treating the cells with DFO, a possible role for GADD153 in 
triggering DFO-induced apoptosis is under investigation. 
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